![Ready or not, AI-based decision support tools are entering oncology clinics Regulators and health systems must adapt](https://cdn.cancerletter.com/media/2024/11/15160117/50-43-4x3-1.jpg)
![Ready or not, AI-based decision support tools are entering oncology clinics Regulators and health systems must adapt](https://cdn.cancerletter.com/media/2024/11/15160117/50-43-4x3-1.jpg)
Cover Story
Regulatory News
By McKenzie Prillaman
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - From the chairs of ECOG-ACRIN: A perspective on indirect costs
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty